加尔纳克结合siRNAs的药理动力学和药理动力学
1Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USA.
Journal of clinical pharmacology
|August 17, 2023
概括
小干扰RNAs (siRNAs) 是一个有前途的新药类. 本综述详细介绍了用于治疗开发的N-甲胺结合siRNAs的药理动力学/药理动力学 (PK/PD).
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物开发 药物开发
- 分子生物学分子生物学
背景情况:
- 小干扰RNAs (siRNAs) 代表了一种针对以前无法治疗的疾病的新疗法.
- 自2018年以来,已批准了五种siRNA药物,许多其他药物正在临床试验中.
- siRNAs具有独特的特性,与小分子和蛋白质疗法不同,需要深入了解它们的PK/PD.
研究的目的:
- 提供关于siRNA PK/PD和临床药理学的全面概述.
- 专注于N-乙银胺 (GalNAc) 结合的siRNAs,这是当前治疗中占主导地位的形式.
- 作为理解siRNA药物开发的基础资源.
主要方法:
- 对siRNA PK/PD和临床药理学现有文献的综述.
- 专注于GalNAc结合的siRNA及其ADME特性.
- 探索PK/PD模型,药物相互作用和特殊人群药理学.
主要成果:
- 裸体siRNAs面临挑战,但结合策略已经导致成功的治疗剂.
- GalNAc结合显著影响siRNA的吸收,分布,新陈代谢和分泌 (ADME).
- 了解PK/PD对于优化siRNA剂量,疗效和安全至关重要.
结论:
- 结合N-乙甲胺胺的siRNAs正在为各种疾病推进治疗选择.
- 对siRNA PK/PD和临床药理学的彻底掌握对于持续的药物开发至关重要.
- 本综述为研究人员和临床医生提供了关于siRNA疗法的基本见解.
相关概念视频
Conjugated Proteins
18.4K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.4K
Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
209
When a drug follows nonlinear pharmacokinetics, its bioavailability, the amount of the drug that reaches the systemic circulation, can change with different doses. This is due to the presence of a saturable pathway. The pathway becomes saturated as the drug concentration increases, decreasing the absorption rate. Consequently, the drug's bioavailability may be lower than expected at higher doses.
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
209
Drug Metabolism: Phase II Reactions
3.9K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.9K
Drug Distribution: Plasma Protein Binding
5.7K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
5.7K
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Pharmacokinetics: Overview
6.5K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
6.5K


